The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Novartis AG, In the Matter of (Alcon, Inc)
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.
D.R. Horton, Inc.
20101183: Novacap Industries III, L.P.; IPL Inc.
20101176: Summit Partners Private Equity Fund VII-A, L.P.; Great Hill Equity Partners II, L.P.
20101172: Grupo Nacional de Chocolates S.A.; Charles Stephen Fehr
20101169: Siemens Aktiengesellschaft; Republic ITS Holdings, LLC
20101168: Investor AB; Molnlycke AB
20101167: Windy City Investments Holdings, L.L.C.; U.S. Bancorp
20101161: Hewlett-Packard Company; ArcSight, Inc.
20101160: UnitedHealth Group Incorporated; A-Life Medical, Inc.
20101159: Trilantic Capital Partners IV L.P.; Fortitech, Inc.
20101138: Hechos con Amor S.A. de C.V.; TSG4 L.P.
20101137: Grupo Kuo S.A.B. de C.V.; TSG4 L.P.
20101109: CA, Inc.; Arcot Systems, Inc.
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
16 C.F.R. Part 321: Mortgage Acts and Practices--Advertising Rule: Notice of Proposed Rulemaking; Request for Comment
SES Performance Review Board; Notice
Privacy Act of 1974; System of Records Notices; Correction
PepsiCo, Inc., In the Matter of
The Commission required that carbonated soft drink company PepsiCo, Inc. restrict its access to confidential business competitive information of rival Dr Pepper Snapple Group as a condition for proceeding with PepsiCo’s proposed $7.8 billion acquisition of its two largest bottlers and distributors, which also distribute Dr Pepper Snapple Group carbonated soft drinks.